Status:
COMPLETED
Lugol's Solution in Addition to Acetic Acid During Colposcopy
Lead Sponsor:
Zydolab - Institute of Cytology and Immune Cytochemistry
Conditions:
Uterine Cervical Dysplasia
Eligibility:
FEMALE
18-80 years
Brief Summary
To assess the benefits of using Lugol's solution in addition to acetic acid during colposcopy in women with cervical dysplasia.
Eligibility Criteria
Inclusion
- women referred for colposcopy due to cervical abnormalities
- written informed consent
Exclusion
- pregnant women
- presence of a language barrier
- history of conization or other treatments on the cervix uteri
- iodine allergy
Key Trial Info
Start Date :
May 31 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
323 Patients enrolled
Trial Details
Trial ID
NCT04415840
Start Date
May 31 2020
End Date
July 1 2021
Last Update
July 19 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Zydolab - Institute of Cytology and Immune Cytochemistry
Dortmund, North Rhine-Westphalia, Germany, 44137
2
Department of Obstetrics and Gynecology of the Ruhr University Bochum
Herne, North Rhine-Westphalia, Germany, 44265